Nabriva Therapeutics plans to raise $80m through an underwritten public offering of shares of its common stock.

The Irish biopharmaceutical company plans to use the funds for general corporate purposes.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

US-based drug discovery company LifeMine Therapeutics has secured $55m in a series A funding round led by WuXi Healthcare Ventures.

LifeMine plans to use the funds towards the development of innovative drugs.

Aldeyra Therapeutics has announced an underwritten public offering of three million shares of its common stock priced at $7.25 a share to raise $25m in total.

See Also:

The US-based biotechnology company plans to use the funds towards the development of ADX-102 and other product candidates.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
"US-based drug discovery company LifeMine Therapeutics has secured $55m in a series A funding round led by WuXi Healthcare Ventures."

Berkeley Lights has formed a partnership with Bayer to enable the latter to use its Beacon platform in drug development process.

The Beacon platform helps in accelerating cell line development and antibody discovery. It will help in enhancing Bayer’s drug discovery and development activities.

Berkeley Lights is a US-based provider of breakthrough platforms for bio-pharmaceutical processes.

Rodin Therapeutics has secured $27m in a venture financing round led by Atlas Venture.

The US-based novel therapeutics developer plans to use the funds towards the development of innovative drugs targeting neurological disorders.